648 — SoftMedx Healthcare Cashflow Statement
0.000.00%
Consumer CyclicalsMicro Cap
Annual cashflow statement for SoftMedx Healthcare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -79.2 | -52.5 | -24.7 | -16.6 | 14.4 |
Depreciation | |||||
Non-Cash Items | 42.5 | 22.5 | 3.99 | 9.96 | -5.97 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 13.5 | 18.4 | 12.9 | 1.79 | -14.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -16.2 | -9.92 | -6.62 | -2.84 | -4.49 |
Capital Expenditures | -0.163 | 0 | -0.524 | -0.532 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 1.16 | 0.305 | -0.173 | 0.203 | -0.845 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.992 | 0.305 | -0.697 | -0.329 | -0.845 |
Financing Cash Flow Items | -5.36 | -0.048 | -0.071 | -0.1 | -0.037 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 7.12 | 7.33 | 9.91 | 2.6 | 10.3 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -8.07 | -2.28 | 2.6 | -0.575 | 4.97 |